Cargando…

The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico

Diabetes is associated with severe COVID-19 and mortality. The aim of the present study was to determine the effect of age on the association between diabetes and mortality in patients with laboratory-confirmed COVID-19 in Mexico. This retrospective cohort study involved patients aged 20 years or ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Woolcott, Orison O., Castilla-Bancayán, Juan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052362/
https://www.ncbi.nlm.nih.gov/pubmed/33863997
http://dx.doi.org/10.1038/s41598-021-88014-z
_version_ 1783679904804503552
author Woolcott, Orison O.
Castilla-Bancayán, Juan P.
author_facet Woolcott, Orison O.
Castilla-Bancayán, Juan P.
author_sort Woolcott, Orison O.
collection PubMed
description Diabetes is associated with severe COVID-19 and mortality. The aim of the present study was to determine the effect of age on the association between diabetes and mortality in patients with laboratory-confirmed COVID-19 in Mexico. This retrospective cohort study involved patients aged 20 years or older with symptoms of viral respiratory disease who were screened for SARS-CoV-2 infection across the System of Epidemiological Surveillance of Viral Respiratory Disease in Mexico from January 1 through November 4, 2020. Cox proportional-hazard regression was used to calculate the hazard ratio for 28-day mortality and its 95% confidence interval (CI). Among 757,210 patients with COVID-19 (outpatients and inpatients), 120,476 (16%) had diabetes and 80,616 died. Among 878,840 patients without COVID-19 (those who tested negative for SARS-CoV-2 infection), 88,235 (10.0%) had diabetes and 20,134 died. Among patients with COVID-19, diabetes was associated with a hazard ratio for death of 1.49 (95% CI 1.47–1.52), adjusting for age, sex, smoking habit, obesity, hypertension, immunodeficiency, and cardiovascular, pulmonary, and chronic renal disease. The strength of the association decreased with age (trend test: P = 0.004). For example, the adjusted hazard ratio for death was 3.12 (95% CI 2.86–3.40) for patients 20–39 years of age; in contrast, the adjusted hazard ratio of death for patients 80 years of age or older was 1.11 (95% CI 1.06–1.16). The adjusted hazard ratios were 1.66 (95% CI 1.58–1.74) in outpatients and 1.14 (95% CI 1.12–1.16) in inpatients. In hospitalized patients 80 years of age or older, no association was observed between diabetes and COVID-19-related mortality (adjusted hazard ratio: 1.03; 95% CI 0.98–1.08). Among patients without COVID-19, the adjusted hazard ratio for death was 1.78 (95% CI 1.73–1.84). In conclusion, in adult patients with COVID-19 in Mexico, the risk of death associated with diabetes decreased with age. No association between diabetes and mortality was observed among inpatients 80 years of age or older. Our findings should be verified in other populations.
format Online
Article
Text
id pubmed-8052362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80523622021-04-22 The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico Woolcott, Orison O. Castilla-Bancayán, Juan P. Sci Rep Article Diabetes is associated with severe COVID-19 and mortality. The aim of the present study was to determine the effect of age on the association between diabetes and mortality in patients with laboratory-confirmed COVID-19 in Mexico. This retrospective cohort study involved patients aged 20 years or older with symptoms of viral respiratory disease who were screened for SARS-CoV-2 infection across the System of Epidemiological Surveillance of Viral Respiratory Disease in Mexico from January 1 through November 4, 2020. Cox proportional-hazard regression was used to calculate the hazard ratio for 28-day mortality and its 95% confidence interval (CI). Among 757,210 patients with COVID-19 (outpatients and inpatients), 120,476 (16%) had diabetes and 80,616 died. Among 878,840 patients without COVID-19 (those who tested negative for SARS-CoV-2 infection), 88,235 (10.0%) had diabetes and 20,134 died. Among patients with COVID-19, diabetes was associated with a hazard ratio for death of 1.49 (95% CI 1.47–1.52), adjusting for age, sex, smoking habit, obesity, hypertension, immunodeficiency, and cardiovascular, pulmonary, and chronic renal disease. The strength of the association decreased with age (trend test: P = 0.004). For example, the adjusted hazard ratio for death was 3.12 (95% CI 2.86–3.40) for patients 20–39 years of age; in contrast, the adjusted hazard ratio of death for patients 80 years of age or older was 1.11 (95% CI 1.06–1.16). The adjusted hazard ratios were 1.66 (95% CI 1.58–1.74) in outpatients and 1.14 (95% CI 1.12–1.16) in inpatients. In hospitalized patients 80 years of age or older, no association was observed between diabetes and COVID-19-related mortality (adjusted hazard ratio: 1.03; 95% CI 0.98–1.08). Among patients without COVID-19, the adjusted hazard ratio for death was 1.78 (95% CI 1.73–1.84). In conclusion, in adult patients with COVID-19 in Mexico, the risk of death associated with diabetes decreased with age. No association between diabetes and mortality was observed among inpatients 80 years of age or older. Our findings should be verified in other populations. Nature Publishing Group UK 2021-04-16 /pmc/articles/PMC8052362/ /pubmed/33863997 http://dx.doi.org/10.1038/s41598-021-88014-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Woolcott, Orison O.
Castilla-Bancayán, Juan P.
The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
title The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
title_full The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
title_fullStr The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
title_full_unstemmed The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
title_short The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
title_sort effect of age on the association between diabetes and mortality in adult patients with covid-19 in mexico
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052362/
https://www.ncbi.nlm.nih.gov/pubmed/33863997
http://dx.doi.org/10.1038/s41598-021-88014-z
work_keys_str_mv AT woolcottorisono theeffectofageontheassociationbetweendiabetesandmortalityinadultpatientswithcovid19inmexico
AT castillabancayanjuanp theeffectofageontheassociationbetweendiabetesandmortalityinadultpatientswithcovid19inmexico
AT woolcottorisono effectofageontheassociationbetweendiabetesandmortalityinadultpatientswithcovid19inmexico
AT castillabancayanjuanp effectofageontheassociationbetweendiabetesandmortalityinadultpatientswithcovid19inmexico